[1] Aboul Enein, B., Bernstein, J., and Neary, A. (2016) Dietary transition and obesity in selected Arabic-speaking countries: a review of the current evidence, EMHJ-Eastern Mediterranean Health Journal 22, 763-770.

[2] Belahsen, R. (2014) Nutrition transition and food sustainability, Proceedings of the Nutrition Society 73, 385-388.

[3] Belhayara, M. I., Mellouk, Z., Hamdaoui, M. S., Bachaoui, M., Kheroua, O., and Malaisse, W. J. (2020) The Metabolic Syndrome: Emerging Novel Insights Regarding the Relationship between the Homeostasis Model Assessment of Insulin Resistance and other Key Predictive Markers in Young Adults of Western Algeria, Nutrients 12, 727.

[4] Rahim, H. F. A., Sibai, A., Khader, Y., Hwalla, N., Fadhil, I., Alsiyabi, H., Mataria, A., Mendis, S., Mokdad, A. H., and Husseini, A. (2014) Non-communicable diseases in the Arab world, The Lancet 383, 356-367.

[5] Julibert, A., Bibiloni, M. d. M., Bouzas, C., Martínez-González, M. Á., Salas-Salvadó, J., Corella, D., Zomeño, M. D., Romaguera, D., Vioque, J., and Alonso-Gómez, Á. M. (2019) Total and subtypes of dietary fat intake and its association with components of the metabolic syndrome in a Mediterranean population at high cardiovascular risk, Nutrients 11, 1493.

[6] Melo, B. F., Sacramento, J. F., Ribeiro, M. J., Prego, C. S., Correia, M. C., Coelho, J. C., Cunha-Guimaraes, J. P., Rodrigues, T., Martins, I. B., and Guarino, M. P. (2019) Evaluating the impact of different hypercaloric diets on weight gain, insulin resistance, glucose intolerance, and its comorbidities in rats, Nutrients 11, 1197.

[7] Kahn, C. R., Wang, G., and Lee, K. Y. (2019) Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome, Journal of Clinical Investigation 129, 3990-4000.

[8] Fabbrini, E., Sullivan, S., and Klein, S. (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications, Hepatology 51, 679-689.

[9] Klein, S., Wadden, T., and Sugerman, H. J. (2002) AGA technical review on obesity, Gastroenterology 123, 882-932.

[10] Smith, G. I., Mittendorfer, B., and Klein, S. (2019) Metabolically healthy obesity: facts and fantasies, Journal of Clinical Investigation 129, 3978-3989.

[11] Hudish, L. I., Reusch, J. E., and Sussel, L. (2019) β cell dysfunction during progression of metabolic syndrome to type 2 diabetes, The Journal of clinical investigation 129.

[12] Yadav, D., Puranik, N., Sen, A., Mishra, M., Kwak, M., and Jin, J.-O. (2020) Metabolic syndrome criteria and its association with type 2 diabetes and cardiovascular diseases, PROGRESS IN NUTRITION 22, 361-369.

[13] Sofer, Y., Nash, Y., Osher, E., Fursht, O., Goldsmith, G., Nahary, L., Shaklai, S., Tordjman, K., Serebro, M., and Touati, E. (2021) Insulin-degrading enzyme higher in subjects with metabolic syndrome, Endocrine, 1-8.

[14] Alberti, G., Zimmet, P., Shaw, J., and Grundy, S. M. (2006) The IDF consensus worldwide definition of the metabolic syndrome, Brussels: International Diabetes Federation 23, 469-480.

[15] Zimmet, P., Magliano, D., Matsuzawa, Y., Alberti, G., and Shaw, J. (2005) The metabolic syndrome: a global public health problem and a new definition, Journal of atherosclerosis and thrombosis 12, 295-300.

[16] Chaix, A., Manoogian, E. N., Melkani, G. C., and Panda, S. (2019) Time-restricted eating to prevent and manage chronic metabolic diseases, Annual review of nutrition 39.

[17] Federation, I. D. (2019) IDF diabetes atlas ninth edition 2019.

[18] Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissen, M., Taskinen, M.-R., and Groop, L. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome, Diabetes care 24, 683-689.

[19] Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., and Das, S. R. (2019) Heart disease and stroke Statistics-2019 update a report from the American Heart Association, Circulation.

[20] Lorenzo, C., Okoloise, M., Williams, K., Stern, M. P., and Haffner, S. M. (2003) The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study, Diabetes care 26, 3153-3159.

[21] Yadav, D., Mahajan, S., Subramanian, S. K., Bisen, P. S., Chung, C. H., and Prasad, G. (2013) Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India, Global journal of health science 5, 142.

[22] Ford, E. S., Giles, W. H., and Dietz, W. H. (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey, Jama 287, 356-359.

[23] Laaksonen, D., Niskanen, L., Nyyssönen, K., Punnonen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., and Salonen, J. (2004) C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men, Diabetologia 47, 1403-1410.

[24] Lim, S., Taskinen, M. R., and Borén, J. (2019) Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome, Obesity Reviews 20, 599-611.

[25] Ryliškytė, L., Navickas, R., Šerpytis, P., Puronaitė, R., Zupkauskienė, J., Jucevičienė, A., Badarienė, J., Rimkienė, M. A., Ryliškienė, K., and Skiauterytė, E. (2019) Association of aortic stiffness, carotid intima-media thickness and endothelial function with cardiovascular events in metabolic syndrome subjects, Blood pressure 28, 131-138.

[26] Saltiel, A. R., and Olefsky, J. M. (2017) Inflammatory mechanisms linking obesity and metabolic disease, The Journal of clinical investigation 127, 1-4.

[27] Srikanthan, K., Feyh, A., Visweshwar, H., Shapiro, J. I., and Sodhi, K. (2016) Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the West Virginian population, International journal of medical sciences 13, 25.

[28] Alberti, K., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., and Smith Jr, S. C. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity, Circulation 120, 1640-1645.

[29] Einhorn, M., FACP, FACE, Daniel. (2003) American College of Endocrinology position statement on the insulin resistance syndrome, Endocrine practice 9, 5-21.

[30] Organization, W. H. (2019) Classification of diabetes mellitus.

[31] Balkau, B. (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR), Diabet med 16, 442-443.

[32] Grundy, S. M., Brewer Jr, H. B., Cleeman, J. I., Smith Jr, S. C., and Lenfant, C. (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition, Circulation 109, 433-438.

[33] Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., and Smith Jr, S. C. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement, Circulation 112, 2735-2752.

[34] O’Neill, S., and O’Driscoll, L. (2015) Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies, Obesity reviews 16, 1-12.

[35] Reaven, G. M. (1988) Role of insulin resistance in human disease, Diabetes 37, 1595-1607.

[36] Reaven, G. M. (1993) Role of insulin resistance in human disease (syndrome X): an expanded definition, Annual review of medicine 44, 121-131.

[37] Nikbakht, H.-A., Rezaianzadeh, A., Seif, M., and Ghaem, H. (2020) Prevalence of metabolic syndrome and its components among a population-based study in south of Iran, PERSIAN Kharameh cohort study, Clinical Epidemiology and Global Health.

[38] Wube, T. B., Nuru, M. M., and Anbese, A. T. (2019) A comparative prevalence of metabolic syndrome among type 2 diabetes mellitus patients in Hawassa university comprehensive specialized Hospital using four different diagnostic criteria, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 12, 1877.

[39] Wang, X., Howell, D., Tang, L., Shao, J., and Ye, Z. (2020) Comparative study on prevalence of metabolic syndrome based on three criteria among adults in Zhejiang province, China: an observational study, BMJ open 10, e035216.

[40] Ranasinghe, P., Mathangasinghe, Y., Jayawardena, R., Hills, A., and Misra, A. (2017) Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review, BMC public health 17, 101.

[41] Saif-Ali, R., Kamaruddin, N. A., Molham, A.-H., Al-Dubai, S. A., and Ngah, W. Z. W. (2020) Relationship of metabolic syndrome defined by IDF or revised NCEP ATP III with glycemic control among Malaysians with Type 2 Diabetes, Diabetology & metabolic syndrome 12, 1-7.

[42] Day, C. (2007) Metabolic syndrome, or What you will: definitions and epidemiology, Diabetes and Vascular Disease Research 4, 32-38.

[43] Phanzu, B. K., Natuhoyila, A. N., Vita, E. K., Kabangu, J.-R. M. B., and Longo-Mbenza, B. (2021) Association between insulin resistance and left ventricular hypertrophy in asymptomatic, Black, sub-Saharan African, hypertensive patients: a case–control study, BMC Cardiovascular Disorders 21, 1-12.

[44] den Biggelaar, L. J., Sep, S. J., Eussen, S. J., Mari, A., Ferrannini, E., van Greevenbroek, M. M., van der Kallen, C. J., Schalkwijk, C. G., Stehouwer, C. D., and Dagnelie, P. C. (2017) Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study, Diabetologia 60, 432-441.

[45] Matthews, D., Hosker, J., Rudenski, A., Naylor, B., Treacher, D., and Turner, R. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia 28, 412-419.

[46] Friedewald, W. T., Levy, R. I., and Fredrickson, D. S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clinical chemistry 18, 499-502.

[47] Zerga, A. A., Bezabih, A. M., Adhanu, A. K., and Tadesse, S. E. (2020) Obesity Indices for Identifying Metabolic Syndrome Among Type Two Diabetes Patients Attending Their Follow-Up in Dessie Referral Hospital, North east Ethiopia, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 13, 1297.

[48] Obeidat, A. A., Ahmad, M. N., Haddad, F. H., and Azzeh, F. S. (2015) Evaluation of several anthropometric indices of obesity as predictors of metabolic syndrome in Jordanian adults, Nutricion hospitalaria 32, 667-677.

[49] He, Y.-H., Chen, Y.-C., Jiang, G.-X., Huang, H.-E., Li, R., Li, X.-Y., Ning, G., and Cheng, Q. (2012) Evaluation of anthropometric indices for metabolic syndrome in Chinese adults aged 40 years and over, European journal of nutrition 51, 81-87.

[50] Motamed, N., Sohrabi, M., Poustchi, H., Maadi, M., Malek, M., Keyvani, H., Amoli, M. S., and Zamani, F. (2017) The six obesity indices, which one is more compatible with metabolic syndrome? A population based study, Diabetes & Metabolic Syndrome: Clinical Research & Reviews 11, 173-177.

[51] Peer, N., Steyn, K., and Levitt, N. (2016) Differential obesity indices identify the metabolic syndrome in Black men and women in Cape Town: the CRIBSA study, Journal of Public Health 38, 175-182.

[52] Swarup, S., Goyal, A., Grigorova, Y., and Zeltser, R. (2021) Metabolic Syndrome. [Updated 2020 Nov 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Accessed 2021, Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459248/.

[53] Robberecht, H., and Hermans, N. (2016) Biomarkers of metabolic syndrome: biochemical background and clinical significance, Metabolic Syndrome and Related Disorders 14, 47-93.

[54] Babikr, W. G., Alshahrani, A. S. A., Hamid, H. G. M., Abdelraheem, A. H. M. K., and Shalayel, M. H. F. (2016) The correlation of HbA1c with body mass index and HDL-cholesterol in type 2 diabetic patients.

[55] Owei, I., Umekwe, N., Provo, C., Wan, J., and Dagogo-Jack, S. (2017) Insulin-sensitive and insulin-resistant obese and non-obese phenotypes: role in prediction of incident pre-diabetes in a longitudinal biracial cohort, BMJ Open Diabetes Research and Care 5.

[56] Iwani, N. A. K. Z., Jalaludin, M. Y., Zin, R. M. W. M., Fuziah, M. Z., Hong, J. Y. H., Abqariyah, Y., Mokhtar, A. H., and Nazaimoon, W. M. W. (2017) Triglyceride to HDL-C ratio is associated with insulin resistance in overweight and obese children, Scientific reports 7, 1-7.

[57] Zadhoush, F., Sadeghi, M., and Pourfarzam, M. (2015) Biochemical changes in blood of type 2 diabetes with and without metabolic syndrome and their association with metabolic syndrome components, Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences 20, 763.

[58] Farid, S. M. (2018) Study of correlation between anthropometric parameters (BMI, WC, WHR) and atherogenic index of plasma (AIP) in type 2 diabetics in Jeddah, Saudi Arabia, GJBB 7, 60-69.

[59] Gayoso-Diz, P., Otero-González, A., Rodriguez-Alvarez, M. X., Gude, F., García, F., De Francisco, A., and Quintela, A. G. (2013) Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study, BMC endocrine disorders 13, 47.

[60] Naveen, L., Santoshi, M., Madhav, D., and Mahesh, V. (2014) A STUDY OF ASSOCIATION OF INSULIN RESISTANCE AND CARDIOMETABOLIC RISK FACTORS IN AN ADULT POPULATION WITH TYPE 2 DIABETES MELLITUS.

[61] Mellouk, Z., Zhang, Y., Bulur, N., Louchami, K., Malaisse, W. J., Ait Yahia, D., and Sener, A. (2012) The metabolic syndrome of fructose-fed rats: Effects of long-chain polyunsaturated ω3 and ω6 fatty acids. III. Secretory behaviour of isolated pancreatic islets, International journal of molecular medicine 29, 285-290.

[62] Mellouk, Z., Hachimi Idrissi, T., Louchami, K., Hupkens, E., Malaisse, W. J., Ait Yahia, D., and Sener, A. (2011) The metabolic syndrome of fructose-fed rats: effects of long-chain polyunsaturated ω3 and ω6 fatty acids. I. Intraperitoneal glucose tolerance test, International journal of molecular medicine 28, 1087-1092.

[63] Agardh, C.-D., and Ahrén, B. (2012) Switching from high-fat to low-fat diet normalizes glucose metabolism and improves glucose-stimulated insulin secretion and insulin sensitivity but not body weight in C57BL/6J mice, Pancreas 41, 253-257.

[64] Cancelas, J., Prieto, P. G., Villanueva-Peñacarrillo, M. L., Valverde, I., and Malaisse, W. (2006) Effects of an olive oil-enriched diet on glucagon-like peptide 1 release and intestinal content, plasma insulin concentration, glucose tolerance and pancreatic insulin content in an animal model of type 2 diabetes, Hormone and metabolic research 38, 98-105.

[65] Malaisse, W. J. (2014) Insulin release: the receptor hypothesis, Diabetologia 57, 1287-1290.

[66] Fu, Z., R Gilbert, E., and Liu, D. (2013) Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes, Current diabetes reviews 9, 25-53.

[67] Sharma, P. (2011) Inflammation and the metabolic syndrome, Indian Journal of Clinical Biochemistry 26, 317.

[68] Carrillo, J. L. M., Campo, J. O. M. D., Coronado, O. G., Gutiérrez, P. T. V., Cordero, J. F. C., and Juárez, J. V. (2018) Adipose Tissue and Inflammation, IntechOpen: https://www.intechopen.com/books/adipose-tissue/adipose-tissue-and-inflammation; accessed on Jan 2021.